Filing Flows › Harvard Bioscience (HBIO) › Free cash flow
Harvard Bioscience (HBIO) free cash flow by quarter
Harvard Bioscience's free cash flow was $877K in Q3 2025 (third quarter 2025), -67% from Q2 2025. Over the last 4 quarters it ranged from $877K (Q3 2025) to $2.7M (Q2 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2025 | $877K | -67% | — |
| Q2 2025 | $2.7M | +8% | — |
| Q1 2025 | $2.5M | +74% | — |
| Q4 2024 | $1.4M | — | — |
Q3 2025 at a glance
Harvard Bioscience, Q3 2025: revenue $20.6M (-6% year over year), operating margin 1.0%, net loss $1.2M, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Harvard Bioscience's free cash flow?
Harvard Bioscience's free cash flow was $877K in Q3 2025 (third quarter 2025), -67% from Q2 2025.
How has Harvard Bioscience's free cash flow changed?
Over the last 4 quarters it ranged from $877K (Q3 2025) to $2.7M (Q2 2025).